Stand-Alone Adjuvant Immunotherapy for Early TNBC?
The role of adjuvant immunotherapy in triple-negative breast cancer (TNBC) remains uncertain. Standard therapy for TNBC includes neoadjuvant pembrolizumab with chemotherapy followed by pembrolizumab, with or without chemotherapy, after surgery. One …